March 9 (Reuters) - Eli Lilly said on Monday a small number of basic Medicare drug plans may not follow the $50 per month cap ...
Eli Lilly warns some Medicare plans may exceed the $50 monthly cap for weight‑loss drugs under a new CMS model.
After years of fighting over compounded weight loss drugs, Hims & Hers and Novo Nordisk are teaming up to sell Ozempic and Wegovy — a shift that could raise costs for patients.
Singaporean photographer Chuanda Tan recently turned 60. Reflecting on his thoughts on his birthday, he wrote, "The wiser path now is simple: return daily to nature and sunlight, and align myself with ...
Dr Jack Mosley, son of the late Dr Michael Mosley, has shared simple snack swaps including chickpeas and nuts that can help ...
Hims & Hers Health, Inc. (NYSE: HIMS) today announced a collaboration with Novo Nordisk as part of a new strategy for weight loss care treatments involving GLP-1s, evolving its US offering to match ...
Novo Nordisk is dismissing its patent infringement lawsuit against telehealth company Hims & Hers, as the two companies have ...
Point32Health, parent of Harvard Pilgrim Healthcare and Tufts Health Plan, is cutting more jobs in a bid to stabilize its finances.
A 2026 informational consumer research report examining the TMates telehealth weight-loss platform, compounded GLP-1 ...
The surgeon who removed a Manawatū woman's stomach following the operation in Turkey is raising concerns about the risks of ...
Hims stock surged more than 40% Monday morning on news that Novo Nordisk will distribute its weight-loss drugs through the Hims platform.
A daily guide for March 9, 2026 featuring tarot card insights for all zodiac signs along with a practical Vastu tip of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results